Radical treatment of organ-localized and locally advanced prostate cancer in Norway--an overview.
In 1998, 28.5% of diagnosed prostate cancer patients in Norway were aged < 71 years and had organ-localized disease and 74.5% of prostate cancer patients aged < 71 years had organ-localized disease. This study compares the number of prostate cancer patients aged < 71 years with organ-localized disease in the five health regions of Norway with the number of patients who were treated with radical intent. In 1998, only 52% of these patients were treated with radical intent; in 1999 this proportion had increased to 73% but large regional differences existed.
Vaage
Sigmund
S
Department of Surgery, Section of Urology, Central Hospital Rogaland, Stavanger, Norway.
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D015994:Incidence; D008297:Male; D009664:Norway / Q000453:epidemiology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D012042:Registries / Q000706:statistics & numerical data
D018931:Antineoplastic Agents, Hormonal